GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Accustem Sciences Inc (OTCPK:ACUT) » Definitions » Research & Development

Accustem Sciences (Accustem Sciences) Research & Development : $0.15 Mil (TTM As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Accustem Sciences Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Accustem Sciences's Research & Development for the three months ended in Mar. 2024 was $0.02 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was $0.15 Mil.

Accustem Sciences Research & Development Historical Data

The historical data trend for Accustem Sciences's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accustem Sciences Research & Development Chart

Accustem Sciences Annual Data
Trend Dec22 Dec23
Research & Development
0.27 0.14

Accustem Sciences Quarterly Data
Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only 0.02 0.02 0.02 0.09 0.02

Accustem Sciences Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.15 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Accustem Sciences  (OTCPK:ACUT) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Accustem Sciences Research & Development Related Terms

Thank you for viewing the detailed overview of Accustem Sciences's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Accustem Sciences (Accustem Sciences) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Accustem Sciences Inc (OTCPK:ACUT) » Definitions » Research & Development
Comparable Companies
Traded in Other Exchanges
N/A
Address
5 Penn Plaza, Suite 1954, Floor 19, New York, NY, USA, 10001
Website
http://www.accustem.com
Accustem Sciences Inc is a life sciences company dedicated to optimizing outcomes for all patients with cancer across the globe. The company takes a holistic view of its role in oncology to empower patients and care team with critical answers and tools and drive innovation in healthcare.